$56.53 -0.79 (-1.38%)
12/3/2009 4:00 PM

Celgene Corp (CELG)

CAPS Rating: 4 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Recs

0
Member Avatar MarvyMarge (< 20) Submitted: 2/2/2008 12:56:47 PM : Outperform Start Price: $59.80 CELG Score: +11.90

I believe Celgene will continue to be one of the top drug makers in the space because of their superior drugs now on the market. Their use of Thalimide in cancer patients has been very successul . Now they have a relatively new drug which has been approved, Revlimid, a miracle drug for cancer patients with multiple myeloma.

Report this Post 0 Comments

Featured Broker Partners